Discover how Venkata Ramanaiah Chintha's AI-powered solution is revolutionizing test plan generation in telecommunications, ...

Roulette machlne for sale R&D Daily丨BioMarin's hemophilia gene therapy rejected by FDA Vertex's three therapies have been accepted by the US FDA for the treatment of more CF patients! New version of ...

S&P 500 components Fortinet and Boston Scientific are among five stocks to watch near buy points as 2024 comes to a close.

Industry leaders say taking time to slowly implement new tools and processes is paying dividends in long-term employee adoption and engagement.

Shares of Vertex Pharmaceuticals Inc. VRTX slid 0.46% to $408.76 Friday, on what proved to be an all-around rough trading ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain ...

This was the stock's fourth consecutive day of gains.

Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster ...

NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

The tower aims to provide new coverage to areas described as "key roadways" by the applicants, including Route 1A, Route 103 ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oruka Therapeutics (ORKA – Research Report), ...